XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2020 $ 567,850 $ 310,619     $ 235,724 $ 21,507
Beginning balance (in shares) at Dec. 31, 2020     41,344,689 1,107,757    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 39,427       39,427  
Other comprehensive loss (12,379)         (12,379)
Issuance of restricted stock (in shares)     292,216      
Tax withholding related to vesting of restricted stock and other (11,287) (11,287)        
Employee stock purchase program 296 296        
Employee stock purchase program (Shares)     5,686      
Stock option exercises 1,213 1,213        
Stock option exercises (in shares)     200,996      
Stock option based compensation expense 344 344        
Restricted stock expense 4,670 4,670        
Non-voting common stock converted to voting common stock in private sale (Shares)     415,504 (415,504)    
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 1,508       1,508  
Cash dividends (1,282)       (1,282)  
Ending balance at Mar. 31, 2021 590,360 305,855     275,377 9,128
Ending balance (in shares) at Mar. 31, 2021     42,259,091 692,253    
Beginning balance at Dec. 31, 2021 715,133 312,294     400,893 1,946
Beginning balance (in shares) at Dec. 31, 2021     43,494,046 125,024    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 34,509       34,509  
Other comprehensive loss (38,452)         (38,452)
Issuance of restricted stock (in shares)     95,537      
Tax withholding related to vesting of restricted stock and other (2,894) (2,894)        
Employee stock purchase program 534 534        
Employee stock purchase program (Shares)     11,119      
Stock option exercises 719 719        
Stock option exercises (in shares)     61,934      
Stock option based compensation expense 391 391        
Restricted stock expense 4,563 4,563        
Non-voting common stock converted to voting common stock in private sale (Shares)     125,024 (125,024)    
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 136       136  
Cash dividends (1,312)       (1,312)  
Ending balance at Mar. 31, 2022 $ 713,327 $ 315,607     $ 434,226 $ (36,506)
Ending balance (in shares) at Mar. 31, 2022     43,787,660